- Home
- GOSS vs PMF Comparison
GOSS vs PMF Comparison
Compare GOSS & PMF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOSS
- PMF
- Stock Information
- Founded
- GOSS 2015
- PMF 2001
- Country
- GOSS United States
- PMF United States
- Employees
- GOSS N/A
- PMF N/A
- Industry
- GOSS Biotechnology: Pharmaceutical Preparations
- PMF Finance/Investors Services
- Sector
- GOSS Health Care
- PMF Finance
- Exchange
- GOSS Nasdaq
- PMF Nasdaq
- Market Cap
- GOSS 246.6M
- PMF 249.4M
- IPO Year
- GOSS 2019
- PMF N/A
- Fundamental
- Price
- GOSS $1.05
- PMF $10.05
- Analyst Decision
- GOSS Strong Buy
- PMF
- Analyst Count
- GOSS 5
- PMF 0
- Target Price
- GOSS $9.20
- PMF N/A
- AVG Volume (30 Days)
- GOSS 963.3K
- PMF 61.3K
- Earning Date
- GOSS 11-07-2024
- PMF 01-01-0001
- Dividend Yield
- GOSS N/A
- PMF 5.36%
- EPS Growth
- GOSS N/A
- PMF N/A
- EPS
- GOSS N/A
- PMF N/A
- Revenue
- GOSS $95,842,000.00
- PMF N/A
- Revenue This Year
- GOSS N/A
- PMF N/A
- Revenue Next Year
- GOSS N/A
- PMF N/A
- P/E Ratio
- GOSS N/A
- PMF N/A
- Revenue Growth
- GOSS N/A
- PMF N/A
- 52 Week Low
- GOSS $0.45
- PMF $7.69
- 52 Week High
- GOSS $1.60
- PMF $10.56
- Technical
- Relative Strength Index (RSI)
- GOSS 59.72
- PMF 57.86
- Support Level
- GOSS $0.98
- PMF $9.94
- Resistance Level
- GOSS $1.09
- PMF $10.50
- Average True Range (ATR)
- GOSS 0.07
- PMF 0.14
- MACD
- GOSS 0.01
- PMF -0.01
- Stochastic Oscillator
- GOSS 74.90
- PMF 28.91
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About PMF PIMCO Municipal Income Fund
PIMCO Municipal Income Fund is a closed-end management investment company. Its primary investment objective is to seek to provide current income exempt from federal income tax. The fund invests a majority of its net assets in municipal bonds that pay interest that is exempt from federal income tax.